Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Stocks To Watch: Apple, Nabors, Sento, Threshold Pharmaceuticals, VCA Antech


Stay in the right path!


Stocks to watch for Thursday, December 28

  • Alcoa (AA) said UAW Local 1050 has ratified a new 4-year labor agreement that covers about 830 employees at the company's Cleveland Works facility. The aluminum company said the UAW represented employees will return to work Jan. 2 after an 8-week strike.
  • FT reports that Apple (AAPL) CEO Steve Jobs was given 7.5M stock options in 2001 without the required authorization from the company's board. The FT says that records that purported to show a full board meeting had taken place to approve Mr Jobs' remuneration, as required by Apple's procedures, were later falsified.
  • BioForm Medical said the Food and Drug Administration has approved Radiesse, a cosmetic dermal filler for the long-lasting correction of moderate to severe facial wrinkles and folds. Shares of BioForm's competitor, Medicis Pharmaceutical (MRX), which makes wrinkle-treatment Restylane, closed down 0.67%.
  • Champion Industries (CHMP) reported fiscal fourth-quarter net earnings of $1.97 million, or 20 cents a share, up from $569,000, or 6 cents a share, in the year-ago period. Revenue in the three months ended Oct. 31 rose 6.6% to $37 million from $34.7 million.
  • Directed Electronics (DEIX) said Ronald Dutt, executive vice president for finance, operations and legal, will be appointed chief financial officer and treasurer, effective Jan. 2. The Vista, Calif.-based designer and marketer of home theater loudspeakers, said Dutt will succeed John Morberg, who is leaving the company.
  • ON Semiconductor (ONNN) said it has agreed to repurchase $70 million of its shares from TPG Semiconductor Holdings LLC and TPG ON Holdings LLC, which together are the company's largest stockholder.
  • Nabors (NBR) said it is initiating a further review of its option-granting practices in light of "issues raised" in a Wall Street Journal article.
  • Sento (SNTO) said it swung to a second-quarter net loss attributable to stockholders of $2.58 million, or 65 cents, due to higher costs of sales after the termination of a client program. In the same period last year, the Salt Lake City-based provider of call center services posted net earnings of $310,000, or 8 cents a share.
  • Standard & Poor's said First Cash Financial Services (FCFS) will replace Republic Bancorp (RBNC) in the SmallCap 600 index after the close of trading on Friday. Citizens Banking (CBCF) is acquiring Republic in a deal expected to close on or about that date.
  • Tapestry Pharmaceuticals (TPPH) named Donald Picker as president, effective Jan. 2. Picker was most recently executive vice president of research and development at Callisto Pharmaceuticals.
  • Threshold (THLD) said it is pleased with the results from the Phase 2 clinical trial of glufosfamide in combination with gemcitabine for the treatment of advanced pancreatic cancer. The cancer treatments developer said 21% of patients in the clinical trial had a partial response.
  • VCA Antech (WOOF) said it sees 2007 revenue of $1.05 billion to $1.08 billion. The operator of veterinary hospitals said it sees annual income of $109 million to $113 million, and per-share income of $1.27 to $1.31.
  • Virgin America was dealt a setback after U.S. regulators ruled that the start-up airline must change its ownership and corporate structure.

Market Summary

  • Asian trading closed with the Hang Seng +1.40%, Nikkei +0.01%, Sensex -0.10%, Shanghai +1.11% and Taiwan flat.
  • A quick look across the pond finds the CAC -0.23%, DAX -0.05%, FTSE -0.10%, Swiss Mkt -0.19% and Stockholm -0.15%.
  • Crude oil is trading +0.30 to 60.64 while gold is +2.0 to 632.3 this morning.
No positions in stocks mentioned.

The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.

Featured Videos